These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22360645)

  • 61. High-flux dialysis lowers plasma leptin concentration in chronic dialysis patients.
    Coyne DW; Dagogo-Jack S; Klein S; Merabet E; Audrain J; Landt M
    Am J Kidney Dis; 1998 Dec; 32(6):1031-5. PubMed ID: 9856520
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phosphate kinetics during hemodialysis: Evidence for biphasic regulation.
    Spalding EM; Chamney PW; Farrington K
    Kidney Int; 2002 Feb; 61(2):655-67. PubMed ID: 11849409
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients.
    van Tellingen A; Grooteman MP; Schoorl M; Bartels PC; Schoorl M; van der Ploeg T; ter Wee PM; Nubé MJ
    Kidney Int; 2002 Aug; 62(2):632-8. PubMed ID: 12110028
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of varying dialysate bicarbonate concentration on serum phosphate.
    Kobrin SM; Raja RM
    ASAIO Trans; 1989; 35(3):423-5. PubMed ID: 2597494
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dialysate calcium concentration and mineral metabolism in long and long-frequent hemodialysis: a systematic review and meta-analysis for a Canadian Society of Nephrology clinical practice guideline.
    Zimmerman DL; Nesrallah GE; Chan CT; Copland M; Komenda P; McFarlane PA; Gangji A; Lindsay R; MacRae J; Pauly RP; Perkins DN; Pierratos A; Rioux JP; Steele A; Suri RS; Mustafa RA
    Am J Kidney Dis; 2013 Jul; 62(1):97-111. PubMed ID: 23591289
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Removal of Cell-Activating Substances Using Dialyzers With Various Permeability Profiles.
    Latosinska A; Hulko M; Speidel R; Mischak H; Storr M; Krause B
    Artif Organs; 2018 Jan; 42(1):78-87. PubMed ID: 28744941
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of an in vitro dialysis system to predict drug removal.
    Hudson JQ; Comstock TJ; Feldman GM
    Nephrol Dial Transplant; 2004 Feb; 19(2):400-5. PubMed ID: 14736965
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Time and exercise improve phosphate removal in hemodialysis patients.
    Vaithilingam I; Polkinghorne KR; Atkins RC; Kerr PG
    Am J Kidney Dis; 2004 Jan; 43(1):85-9. PubMed ID: 14712431
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro characterization of oritavancin clearance from human blood by low-flux, high-flux, and continuous renal replacement therapy dialyzers.
    Kumar A; Mann HJ; Keshtgarpour M; Flynn MA; Deng H; Far AR; Parr TR; Moriarty SR
    Int J Artif Organs; 2011 Nov; 34(11):1067-74. PubMed ID: 22183520
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evolution of serum phosphate in long intermittent hemodialysis.
    Fajardo L; Campistrús N; Ríos P; Gómez T
    Kidney Int Suppl; 2003 Jun; (85):S66-8. PubMed ID: 12753269
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Improvements in phosphate control with short daily in-center hemodialysis.
    Yuen D; Richardson RM; Chan CT
    Clin Nephrol; 2005 Nov; 64(5):364-70. PubMed ID: 16312264
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Role of Dialysis Membranes on Intradialytic Selenium Removal and on Selenium Status in Patients Receiving Renal Replacement Therapy.
    Sonikian M; Dona A; Skarakis J; Trompouki S; Miha T; Karatzas I; Spiliopoulou C
    Blood Purif; 2016; 41(1-3):94-9. PubMed ID: 26624220
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phosphate removal and hemodialysis conditions.
    Pohlmeier R; Vienken J
    Kidney Int Suppl; 2001 Feb; 78():S190-4. PubMed ID: 11169009
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prescriptions of dialysate potassium concentration during short daily or long nocturnal (high dose) hemodialysis.
    Leypoldt JK; Agar BU; Bernardo AA; Culleton BF
    Hemodial Int; 2016 Apr; 20(2):218-25. PubMed ID: 26179136
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Amino acid losses during hemodialysis: effects of high-solute flux and parenteral nutrition in acute renal failure.
    Hynote ED; McCamish MA; Depner TA; Davis PA
    JPEN J Parenter Enteral Nutr; 1995; 19(1):15-21. PubMed ID: 7658594
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endotoxemia after high cutoff hemodialysis for treatment of patient with multiple myeloma can be prevented by using ultrapure dialysate: a case report.
    Gong D; Ji D; Zhang K; Huang X; Huang G; Xu B; Liu Z
    Hemodial Int; 2013 Oct; 17(4):618-23. PubMed ID: 23113894
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Determination of vancomycin and gentamicin clearance in an in vitro, closed loop dialysis system.
    Jang SM; Cardone KE; Nolin TD; Mason DL; Grabe DW
    BMC Nephrol; 2014 Dec; 15():204. PubMed ID: 25526750
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A regenerable potassium and phosphate sorbent system to enhance dialysis efficacy and device portability: an in vitro study.
    Wester M; Simonis F; Gerritsen KG; Boer WH; Wodzig WK; Kooman JP; Joles JA
    Nephrol Dial Transplant; 2013 Sep; 28(9):2364-71. PubMed ID: 23825104
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hemodialysis clearance of iosimenol, a novel iso-osmolar radiographic contrast medium.
    Hirao Y; Kashiyama E; Umehara K; Kohno M; Ikei N; Hogstrom B
    Acta Radiol; 2014 Oct; 55(8):938-44. PubMed ID: 24123996
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Physiologic volume of phosphorus during hemodialysis: predictions from a pseudo one-compartment model.
    Leypoldt JK; Akonur A; Agar BU; Culleton BF
    Hemodial Int; 2012 Oct; 16 Suppl 1():S15-9. PubMed ID: 23036030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.